½ÃÀ庸°í¼­
»óǰÄÚµå
1361124

´Ü¹éÁú ¶óº§¸µ ½ÃÀå - Á¦Ç° À¯Çü, ¶óº§¸µ ¹æ¹ý, ¿ëµµ, ÃÖÁ¾ »ç¿ëÀÚº° & ¼¼°è ¿¹Ãø(2023-2032³â)

Protein Labeling Market - By Product Type (Kits & Reagents), Labeling Method (In-vitro {Enzymatic labeling} In-vivo), Application (Fluorescence Microscopy), End-user (Pharmaceutical and Biotechnology Companies) & Global Forecast 2023 - 2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Global Market Insights Inc. | ÆäÀÌÁö Á¤º¸: ¿µ¹® 220 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°è ´Ü¹éÁú ¶óº§¸µ ½ÃÀå ±Ô¸ð´Â 2023³âºÎÅÍ 2032³â±îÁö CAGR 10.6%·Î È®´ëµÉ Àü¸ÁÀÔ´Ï´Ù.

»ý¸í°úÇÐ ºÐ¾ßÀÇ ¿¬±¸°³¹ßÀ» Àå·ÁÇÏ´Â Àμ¾Æ¼ºê, º¸Á¶±Ý, ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©¸¦ Á¦°øÇÔÀ¸·Î½á Á¤ºÎ´Â ´Ü¹éÁú ¶óº§¸µ ±â¼úÀÇ Çõ½Å°ú ¹ßÀüÀ» ÃËÁøÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¤Ã¥Àº ¿¬±¸ ±â°ü°ú »ê¾÷°èÀÇ Çù¾÷À» ÃËÁøÇÏ°í ´Ù¾çÇÑ ºÐ¾ß¿¡¼­ ´Ü¹éÁú ¶óº§¸µ ¼Ö·ç¼ÇÀÇ Ã¤Åÿ¡ µµ¿òÀÌ µÇ´Â ȯ°æÀ» Á¶¼ºÇÏ¿© ±Ã±ØÀûÀ¸·Î ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ ¼ö ÀÖ½À´Ï´Ù.

2023³â 5¿ù, ÅØ»ç½º ÁÖÁ¤ºÎ´Â ´ëü ´Ü¹éÁú Ç¥½Ã °ü·Ã ¹ý¾ÈÀ» ½ÂÀÎÇÏ¿© ¾Æ³¯·Î±× Á¦Ç° ¹× ¼¼Æ÷¹è¾ç Á¦Ç°ÀÇ Åõ¸í¼º Çâ»óÀ» Àǹ«È­Çß½À´Ï´Ù. ÅØ»ç½º ¹× ³²¼­ºÎ ¼Ò »çÀ°ÀÚ Çùȸ(TSCRA)¿¡ µû¸£¸é, »ó¿ø ¹ý¾È(SB) 664´Â ÇÏ¿ø ¹ý¾È(HB) 1788°ú ÇÔ²² '¸ðÁ¶ À°·ù' Á¦Ç°¿¡ ´ëÇÑ ±â¸¸ÀûÀÎ ÆÇ¸Å ¹æ½ÄÀ¸·ÎºÎÅÍ ¼ÒºñÀÚ¸¦ º¸È£ÇÏ´Â °ÍÀ» ¸ñÇ¥·Î Çϰí ÀÖ½À´Ï´Ù. ÀÌ ¹ý¾ÈÀº ¾Æ³¯·Î±× Á¦Ç° ¹× ¼¼Æ÷ ¹è¾ç Á¦Ç°¿¡ ´ëÇØ º¸´Ù Åõ¸íÇÑ Ç¥½Ã¸¦ Àǹ«È­ÇÏ´Â ³»¿ëÀ» ´ã°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¹æÇâÀ¸·ÎÀÇ ³ë·ÂÀÌ Áõ°¡ÇÏ¸é ´Ü¹éÁú ¶óº§¸µ »ê¾÷ÀÇ °ÇÀüÇÑ ¼ºÀåÀ» ±â´ëÇÒ ¼ö ÀÖÀ» °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

Àüü ´Ü¹éÁú ¶óº§¸µ ½ÃÀåÀº Á¦Ç° À¯Çü, ¶óº§¸µ ¹æ¹ý, ¿ëµµ, ÃÖÁ¾ »ç¿ëÀÚ, Áö¿ªº°·Î ºÐ·ùµË´Ï´Ù.

´Ü¹éÁú ¶óº§¸µ ¼­ºñ½º »ê¾÷Àº »ý¸í°øÇÐ, Á¦¾à ¹× ¿¬±¸ ºÐ¾ßÀÇ È®´ë¿¡ ÈûÀÔ¾î 2023³âºÎÅÍ 2032³â±îÁö ÀûÀýÇÑ CAGR·Î ¼ºÀåÇÒ °ÍÀÔ´Ï´Ù. ´Ü¹éÁú ±â¹Ý Ä¡·á ¹× Áø´Ü¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁü¿¡ µû¶ó Á¤È®ÇÑ ¶óº§¸µÀº ÀǾàǰ °³¹ß ¹× Áúº´ ÀÌÇØ¿¡ ÇʼöÀûÀÔ´Ï´Ù. ¶ÇÇÑ, ´Ü¹éÁúüÇÐ ¹× °³ÀÎ ¸ÂÃãÇü ÀÇ·áÀÇ ¹ßÀüÀº ¸ÂÃãÇü ´Ü¹éÁú ¶óº§¸µ ¼­ºñ½º¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. Á¤È®ÇÑ ´Ü¹éÁú ¶óº§¸µÀº ½ÇÇè, ¾à¹° ¿¬±¸ ¹× Áø´Ü Å×½ºÆ®ÀÇ È¿À²¼ºÀ» ³ô¿© ÀÌ ºÐ¾ß ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

´Ü¹éÁú ½Äº° ¹× Á¤·®È­¿¡¼­ Áú·® ºÐ¼® ±â¼úÀÇ Áß¿äÇÑ ¿ªÇÒ·Î ÀÎÇØ Áú·® ºÐ¼® ºÎ¹®Àº 2032³â±îÁö ÁÖ¸ñÇÒ ¸¸ÇÑ ´Ü¹éÁú ¶óº§¸µ ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Áú·® ºÐ¼®Àº µ¿À§ ¿ø¼Ò ű׳ª Çü±¤ ű׸¦ Á¤È®ÇÏ°Ô Ç¥ÁöÇÔÀ¸·Î½á ¿¬±¸ÀÚµéÀÌ ´Ü¹éÁú »ùÇÃÀ» Á¤È®ÇÏ°Ô ÃßÀûÇÏ°í ºÐ¼®ÇÒ ¼ö ÀÖ°Ô ÇØÁÝ´Ï´Ù. µû¶ó¼­ ´Ü¹éÁúüÇÐ, ½Å¾à°³¹ß, ¹ÙÀÌ¿À¸¶Ä¿ ¿¬±¸ µî Áú·®ºÐ¼®ÀÌ º¹ÀâÇÑ »ý¹°ÇÐÀû °úÁ¤°ú Áúº´ ¸ÞÄ¿´ÏÁòÀ» ±Ô¸íÇÏ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» ÇÏ´Â ºÐ¾ß¿¡¼­ ´Ü¹éÁú ¶óº§¸µ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

À¯·´ÀÇ ´Ü¹éÁú ¶óº§¸µ »ê¾÷Àº ´Ù¾çÇÑ ¿äÀÎÀ¸·Î ÀÎÇØ Å©°Ô ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. Á¦¾à ¹× »ý¸í°øÇÐ ºÐ¾ß¿¡¼­ À¯·´ÀÌ Â÷ÁöÇÏ´Â ºñÁßÀÌ Ä¿Áö¸é¼­ ´Ü¹éÁú ¶óº§¸µ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖÀ¸¸ç, ±â¾÷µéÀº ¿¬±¸°³¹ß¿¡ ´ëÇÑ ÅõÀÚ¸¦ ´Ã¸®°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¾ö°ÝÇÑ ±ÔÁ¦ ±âÁØÀº Á¤È®ÇÑ ¶óº§¸µ ±â¼úÀÇ Ã¤ÅÃÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¾Ï ¿¬±¸ ¹× °³ÀÎ ¸ÂÃãÇü ÀÇ·á¿¡¼­ Ç¥Áö ´Ü¹éÁúÀÇ »ç¿ë Áõ°¡¿Í °°Àº »ç·Ê´Â ÀÌ Áö¿ªÀÇ »ê¾÷ ¼ºÀåÀ» µÞ¹ÞħÇϰí ÀÖÀ¸¸ç, ÷´Ü ÀÇ·á ¿¬±¸ ¹× Áø´Ü¿¡ ´ëÇÑ °ü·Ã¼ºÀ» º¸¿©ÁÝ´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú Á¶»ç ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ´Ü¹éÁú ¶óº§¸µ ¾÷°è ÀλçÀÌÆ®

  • »ýÅÂ°è ºÐ¼®
  • ¾÷°è¿¡ ´ëÇÑ ¿µÇâ¿äÀÎ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¾÷°èÀÇ ÀáÀçÀû ¸®½ºÅ©£¦°úÁ¦
  • ¼ºÀå °¡´É¼º ºÐ¼®
  • COVID-19ÀÇ ¿µÇ⠺м®
  • ±ÔÁ¦ »óȲ
    • ¹Ì±¹
    • À¯·´
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®

Á¦4Àå °æÀï ±¸µµ

  • ¼­·Ð
  • ±â¾÷ ¸ÅÆ®¸¯½º ºÐ¼®
  • ÁÖ¿ä ½ÃÀå ±â¾÷ - °æÀï ºÐ¼®
  • °æÀï Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º
  • Àü·« ´ë½Ãº¸µå

Á¦5Àå ´Ü¹éÁú ¶óº§¸µ ½ÃÀå : Á¦Ç° À¯Çüº°, 2018³â-2032³â

  • ÁÖ¿ä µ¿Çâ : Á¦Ç° À¯Çüº°
  • ŰƮ ¹× ½Ã¾à
  • ¼­ºñ½º

Á¦6Àå ´Ü¹éÁú ¶óº§¸µ ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø : Ç¥Áö ¹æ¹ýº°, 2018³â-2032³â

  • ÁÖ¿ä µ¿Çâ : Ç¥Áö ¹æ¹ýº°
  • ÀκñÆ®·Î
    • »ö¼Ò Ç¥Áö
    • È¿¼Ò ¶óº§¸µ
    • ³ª³ëÀÔÀÚ Ç¥Áö
    • ºÎÀ§ ƯÀÌÀû Ç¥Áö
  • »ýü³»
    • ±¤¹ÝÀÀ¼º Ç¥Áö
    • »ýü Á÷±³¼º Ç¥Áö

Á¦7Àå ´Ü¹éÁú ¶óº§¸µ ½ÃÀå : ¿ëµµº°, 2018³â-2032³â

  • ÁÖ¿ä µ¿Çâ : ¿ëµµº°
  • ¼¿ ±â¹Ý ¾î¼¼ÀÌ
  • Çü±¤ Çö¹Ì°æ
  • ¸é¿ªÇÐÀû ¹æ¹ý
  • Áú·®ºÐ¼®
  • ´Ü¹éÁú ¸¶ÀÌÅ©·Î¾î·¹ÀÌ

Á¦8Àå ´Ü¹éÁú ¶óº§¸µ ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°, 2018³â-2032³â

  • ÁÖ¿ä µ¿Çâ : ÃÖÁ¾»ç¿ëÀÚº°
  • º´¿ø ¹× Ŭ¸®´Ð
  • Áø´Ü ½ÇÇè½Ç
  • Á¦¾à ±â¾÷ ¹× ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ±â¾÷
  • ±âŸ ÃÖÁ¾»ç¿ëÀÚ

Á¦9Àå ´Ü¹éÁú ¶óº§¸µ ½ÃÀå : Áö¿ªº°, 2018³â-2032³â

  • ÁÖ¿ä µ¿Çâ : Áö¿ªº°
  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
  • À¯·´
    • µ¶ÀÏ
    • ¿µ±¹
    • ÇÁ¶û½º
    • ½ºÆäÀÎ
    • ÀÌÅ»¸®¾Æ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ÀϺ»
    • Áß±¹
    • Àεµ
    • È£ÁÖ
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
    • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«(MEA)
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ±âŸ MEA

Á¦10Àå ±â¾÷ °³¿ä

  • Thermo Fisher Scientific Inc.
  • Merck & Co., Inc
  • F. Hoffmann-La Roche
  • Atlantis Bioscience Pte Ltd.
  • LI-COR, Inc.
  • Promega Corporation
  • New England Biolabs
  • PerkinElmer Inc.
  • Bio-Rad Laboatories
  • Agilent Technologies
LSH 23.10.30

Global Protein Labeling Market size will expand at 10.6% CAGR from 2023 to 2032, driven by supportive government policies across both developed and developing economies. By offering incentives, grants, and regulatory frameworks that encourage research and development in life sciences, governments can facilitate innovations and advancements in protein labeling technologies. These policies can also promote collaborations between research institutions and industry, fostering a conducive environment for the adoption of protein labeling solutions in various sectors, thus ultimately driving market growth.

In May 2023, the Texas government approved a bill concerning the labeling of alternative proteins, mandating increased transparency for analog and cell-cultured products. As per the Texas & Southwestern Cattle Raisers Association (TSCRA), Senate Bill (SB) 664, in conjunction with its counterpart House Bill (HB) 1788, aims to shield consumers from deceptive marketing practices concerning "imitation meat" items. This legislation enforces more transparent labeling for analog and cell-cultured products. More such efforts in this direction will help create a healthy growth outlook for the protein labeling industry.

The overall protein labeling market is categorized based on product type, labeling method, application, end-user, and region.

The protein labeling services industry will expand at a decent CAGR between 2023 and 2032, driven by the expanding fields of biotechnology, pharmaceuticals, and research. With increasing emphasis on protein-based therapies and diagnostics, precise labeling is crucial for drug development and disease understanding. Additionally, advancements in proteomics and personalized medicine contribute to the growing need for tailored protein labeling services. Accurate protein labeling enhances the efficacy of experiments, drug studies, and diagnostic tests, fostering demand in these sectors.

The mass spectroscopy segment could amass a notable protein labeling market share by 2032 due to the critical role of mass spectroscopy techniques in identifying and quantifying proteins. In mass spectrometry, precise labeling with isotopic or fluorescent tags enables researchers to track and analyze protein samples accurately. This drives demand for labeled proteins in fields like proteomics, drug discovery, and biomarker research, where mass spectrometry plays a vital role in unraveling complex biological processes and disease mechanisms.

Europe protein labeling industry is experiencing significant expansion due to various factors. Europe's strong presence in the pharmaceutical and biotechnology sectors fuels the demand for protein labeling, with companies increasingly investing in research and development. Additionally, strict regulatory standards encourage the adoption of precise labeling techniques. Instances such as the increasing use of labeled proteins for cancer research and personalized medicine underscore the industry's growth in the region, indicating its relevance in advanced medical research and diagnostics.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market definition
  • 1.2 Base estimates & calculations
  • 1.3 Forecast parameters
  • 1.4 COVID-19 impact analysis at global level
  • 1.5 Data validation
  • 1.6 Data Sources
    • 1.6.1 Primary
    • 1.6.2 Secondary
      • 1.6.2.1 Paid sources
      • 1.6.2.2 Public sources

Chapter 2 Executive Summary

  • 2.1 Protein labeling industry 360 degree synopsis, 2018 - 2032
    • 2.1.1 Business trends
    • 2.1.2 Regional trends
    • 2.1.3 Product type trends
    • 2.1.4 Labeling method trends
    • 2.1.5 Application trends
    • 2.1.6 End-user trends

Chapter 3 Protein Labeling Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing R&D expenditure pertaining to proteomics research
      • 3.2.1.2 Rising demand for biomarker discovery
      • 3.2.1.3 Increasing technological advancements
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Dearth of skilled professionals
  • 3.3 Growth potential analysis
    • 3.3.1 By product type
    • 3.3.2 By labeling method
    • 3.3.3 By application
    • 3.3.4 By end-user
  • 3.4 COVID- 19 impact analysis
  • 3.5 Regulatory landscape
    • 3.5.1 U.S.
    • 3.5.2 Europe
  • 3.6 Porter's analysis
  • 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

  • 4.1 Introduction
  • 4.2 Company matrix analysis, 2022
  • 4.3 Competitive analysis of major market players
  • 4.4 Competitive positioning matrix
  • 4.5 Strategy dashboard

Chapter 5 Protein Labeling Market, By Product Type, 2018 - 2032 (USD Million)

  • 5.1 Key trends, by product type
  • 5.2 Kits & reagents
  • 5.3 Services

Chapter 6 Protein Labeling Market Size and Forecast, By Labeling Method, 2018 - 2032 (USD Million)

  • 6.1 Key trends, by labeling method
  • 6.2 In-vitro
    • 6.2.1 Dye-based labeling
    • 6.2.2 Enzymatic labeling
    • 6.2.3 Nanoparticle labeling
    • 6.2.4 Site-specific labeling
  • 6.3 In-vivo
    • 6.3.1 Photoreactive labeling
    • 6.3.2 Bioorthogonal labeling

Chapter 7 Protein Labeling Market, By Application, 2018 - 2032 (USD Million)

  • 7.1 Key trends, by application
  • 7.2 Cell-based Assays
  • 7.3 Fluorescence Microscopy
  • 7.4 Immunological Techniques
  • 7.5 Mass Spectrometry
  • 7.6 Protein Microarray

Chapter 8 Protein Labeling Market, By End-user, 2018 - 2032 (USD Million)

  • 8.1 Key trends, by end-user
  • 8.2 Hospitals and clinics
  • 8.3 Diagnostic laboratories
  • 8.4 Pharmaceutical and biotechnology companies
  • 8.5 Other end-users

Chapter 9 Protein Labeling Market, By Region, 2018 - 2032 (USD Million)

  • 9.1 Key trends, by region
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Spain
    • 9.3.5 Italy
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 Rest of Asia Pacific
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Rest of Latin America
  • 9.6 MEA
    • 9.6.1 South Africa
    • 9.6.2 Saudi Arabia
    • 9.6.3 Rest of MEA

Chapter 10 Company Profiles

  • 10.1 Thermo Fisher Scientific Inc.
  • 10.2 Merck & Co., Inc
  • 10.3 F. Hoffmann-La Roche
  • 10.4 Atlantis Bioscience Pte Ltd.
  • 10.5 LI-COR, Inc.
  • 10.6 Promega Corporation
  • 10.7 New England Biolabs
  • 10.8 PerkinElmer Inc.
  • 10.9 Bio-Rad Laboatories
  • 10.10 Agilent Technologies
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦